HS code: 30022000
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2018 | <hidden> |
2019 | <hidden> |
Total: | <hidden> |
Period | Weight, tons. |
---|---|
2018 | <hidden> |
2019 | <hidden> |
Total: | <hidden> |
Group product | 2018 | 2019 | Ch. | ∑ (2018-2019) | Ratio |
---|---|---|---|---|---|
06 3002200001: vaccine for humans against rubella | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 3002200002: vaccine for humans against hepatitis B | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
06 3002200009: Other vaccine for humans | <hidden> | <hidden> | <hidden>% | <hidden> | <hidden>% |
Total: | <hidden> | <hidden> | <hidden> |
№ | Country | ∑ (2018-2019) | Ratio |
---|---|---|---|
1 | Turkey | <hidden> | <hidden>% |
The total for all countries: | <hidden> | 100% |
№ | Region | ∑ (2018-2019) | Ratio |
---|---|---|---|
1 | Moskva | <hidden> | <hidden>% |
2 | Moskovskaya oblast | <hidden> | <hidden>% |
3 | Sankt-Peterburg | <hidden> | <hidden>% |
4 | Leningradskaya oblast | <hidden> | <hidden>% |
By all regions: | <hidden> | 100% |